Vedanta Limited has granted Employee Stock Options Scheme worth Rupees 450 crore for fiscal year 2025. This ESOS allows employees to purcha...

Darwinbox, a SaaS HR platform, completed a Rs 86-crore ESOP buyback, its third in four years, benefiting over 350 employees. The company's ...

Stocks in news: Equity markets started positively, with modest gains during a subdued session. Key focus includes ICICI Bank's clarificatio...

While some startups have shown profits, even those who haven’t been able to get into the black yet reported strong revenue and Ebitda numbe...

On Sunday, the Indian government issued orders to block 138 betting and gambling apps and 94 loan providing apps due to foreign links on an...

Companies are upbeat about the economy and consumer confidence as most see Covid-19 as being unlikely to have an impact on the business cyc...

With governance in sharp focus at India Inc, corporate boards and top management may find it tougher to push their agenda if not aligned wi...

YES Bank will enhance pool of share in ESOP to 225 million shares from 75 million to grant them to employees.

Centrum maintained its ‘buy’ rating on Pfizer with a target price of Rs 5,000.

Here’s breaking down the pre-market actions.

Lupin has signed an agreement with Boehringer to develop a new drug for cancer patients.

Sell Vedanta at a price target of Rs 145.

HR heads and executive search experts said variable pay is increasingly becoming a game changer in CXO compensation.

Meanwhile, Blue Star has announced appointment of Shailesh Haribhakti as its chairman.

The amount at stake is substantially higher than average salaries companies pay to staff.

The S&P BSE Sensex surged over 100 points in the morning trade on Monday, led by gains in Infosys, ICICI Bank, HDFC Bank, HDFC, and Sun Pha...

Rahul Dhir, managing director and chief executive officer (CEO) of Cairn India, is expected to get his final lot of 22.38 lakh of company's...